Ingredient
Polyperfluoromethylisopropyl Ether
Polyperfluoromethylisopropyl Ether is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is endocrine disruptor and absorbed into the body.
- PFMIE
- Fluorinated Ether Polymer
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Polyperfluoromethylisopropyl Ether and pregnancy
Caution Advised
- Endocrine disruptor
- Absorbed into the body
- Fetal development
Polyperfluoromethylisopropyl Ether is a fluorinated compound (PFAS) used in cosmetics to create water-resistant, long-wearing products. PFAS compounds are synthetic chemicals known for their extreme persistence in the environment and potential to accumulate in the body. While this specific polymer lacks extensive pregnancy studies, broader PFAS research has raised concerns. According to the American College of Obstetricians and Gynecologists (ACOG), some PFAS compounds have been associated with lower birth weights, developmental delays, and potential endocrine disruption. The CDC has documented that PFAS compounds can cross the placenta, though the degree varies by specific compound structure. While medical consensus on this particular ingredient is not established, many toxicologists and environmental health experts recommend a precautionary approach to PFAS exposure during pregnancy. The European Environment Agency has called for minimizing PFAS exposure in vulnerable populations. Women concerned about potential risks may choose to avoid products with fluorinated ingredients during pregnancy.
Polyperfluoromethylisopropyl Ether and breastfeeding
Caution Advised
- Passes into breast milk
- Infant exposure
Polyperfluoromethylisopropyl Ether is a PFAS compound—a class of fluorinated chemicals known for their persistence and potential bioaccumulation. While topical application typically results in lower systemic absorption than ingestion, PFAS compounds can be absorbed through skin to varying degrees. Research on PFAS compounds broadly has documented their presence in breast milk. A 2022 study in Environmental Science & Technology found various PFAS compounds in breast milk samples, though the sources of exposure were primarily dietary and environmental rather than cosmetic. The specific transfer rate of this polymer to breast milk is unknown, but its fluorinated structure raises theoretical concerns. While definitive data is lacking, the precautionary principle suggests limiting exposure to PFAS compounds during breastfeeding when possible. Many lactation consultants and environmental health advocates recommend avoiding products with fluorinated ingredients during breastfeeding. The long-term effects of infant PFAS exposure are still being studied.
Polyperfluoromethylisopropyl Ether and postpartum
Safe to Use
- Environmental pollutant
Polyperfluoromethylisopropyl Ether is a fluorinated polymer used for its water-repellent properties in cosmetics. For postpartum women not breastfeeding, the immediate health concerns are reduced compared to pregnancy or lactation periods. However, PFAS compounds' environmental persistence and potential bioaccumulation remain considerations. While topical cosmetic use poses lower risk than dietary sources, individuals concerned about cumulative PFAS exposure may still choose to minimize use of products containing fluorinated ingredients.
Polyperfluoromethylisopropyl Ether and trying to conceive
Caution Advised
- Hormone disruptor
- Builds up in tissue
- Fertility effects
Polyperfluoromethylisopropyl Ether is a PFAS compound, and research on PFAS broadly has raised concerns about reproductive health. Studies have found associations between elevated PFAS levels and longer time to pregnancy, though most research has focused on dietary and occupational exposure rather than cosmetics. The persistence of PFAS compounds means they can accumulate in the body over time. Women trying to conceive may wish to minimize PFAS exposure before pregnancy as a precautionary measure, as some compounds can take years to be eliminated from the body. While cosmetic exposure is typically lower than dietary sources, reducing unnecessary PFAS products is often recommended by environmental health specialists.
Polyperfluoromethylisopropyl Ether and PCOS
Caution Advised
- Endocrine disruptor
- Interferes with hormones
Polyperfluoromethylisopropyl Ether belongs to the PFAS family of fluorinated compounds. Research on PFAS broadly has suggested potential endocrine-disrupting properties, though specific effects on PCOS are not well studied. Some research has found associations between PFAS exposure and altered reproductive hormone levels. A 2020 study in Environmental Health Perspectives found certain PFAS compounds were associated with changes in sex hormone binding globulin. For women with PCOS, who already experience hormonal imbalances, additional endocrine disruption is theoretically concerning. While this specific polymer hasn't been studied in PCOS populations, the precautionary principle suggests women with PCOS may want to minimize exposure to PFAS compounds. The ingredient is not essential for effective skincare, and alternatives without endocrine disruption concerns are available.
Polyperfluoromethylisopropyl Ether and general use
Safe to Use
- Environmental pollutant
- Endocrine disruptor
Polyperfluoromethylisopropyl Ether is a fluorinated polymer (PFAS compound) used in cosmetics to create water-resistant, long-wearing products. PFAS chemicals are valued in industry for their unique properties but have raised environmental and health concerns. PFAS compounds are extremely persistent in the environment and can accumulate in human bodies over time. While acute toxicity from cosmetic use is not a concern, long-term exposure to various PFAS compounds has been associated with potential health effects including immune system impacts and possible endocrine disruption in some studies. Several European countries are moving toward restricting PFAS in consumer products, including cosmetics. While this specific polymer is still permitted, the trend toward PFAS-free formulations reflects growing precautionary concerns. The general public can safely use products with this ingredient, though those concerned about cumulative PFAS exposure may prefer alternatives.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Polyperfluoromethylisopropyl Ether, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store